Dong-A sales rise, operating profits drop

Published: 2011-11-01 06:58:00

Updated: 2011-11-01 06:58:00

Stimulated by robust Bacchus-F, OTC version of popular Bacchus-D drink, Dong-A Pharmaceutical posted 241.9 billion won in revenue for the July-Sept. period, up a 14 percent increase from 212.1 billion won last year.

The company enjoyed a spike in sales after Bacchus-F hit supermarkets’ shelves...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK